Professional Documents
Culture Documents
Group 1b Crohns Disease Vs Hirschsprung Disease
Group 1b Crohns Disease Vs Hirschsprung Disease
CROHN’S DISEASE
VS
HIRSCHSPRUNG
DISEASE
BSN 4A
INFLAMMATORY BOWEL DISEASE: CROHN'S DISEASE
Definition
● Two conditions are categorized as inflammatory bowel disease: ulcerative colitis and
Crohn's disease. Both involve the development of ulcers of the mucosa or
submucosa layers of the colon and rectum.
Crohn's Disease
● A type of IBD that causes inflammation and ulcer formation in the GI tract
● The disease can be found in both large and small intestine most likely found terminal
of ileum and start of the colon
Clinical Manifestations
● Prominent lower right quadrant abdominal pain and diarrhea unrelieved by
defecation.
● Crampy abdominal pains
● Abdominal tenderness and spasm
● Weight loss, malnutrition, and secondary anemia
● Chronic diarrhea and steatorrhea
● Intra-abdominal and anal abscesses
● Fever and leukocytosis
● Fistula and fissures
Diagnostic and Laboratory Findings
Sindhu 2015
BARIUM SERIES
RESULT INTERPRETATION
COLONOSCOPY
Erythematous and friable mucosa with
numerous pseudo polyps
PRECIPITATING
PREDISPOSING FACTORS FACTORS
• Age
• Environment
• Gender
• Smoking
• Race
• Abnormal activation of
• Family History
the immune system
• Infections
Inflammation
S/s: Persistent
Transmural spread of
watery diarrhea &
inflammation
bleeding
Extensive inflammation
Subjective cues: Acute Pain Short Term Goal: Independent: Short Term Goal:
“Grabe ang sakit related to Gl After 30 minutes of ● Provide some ● This is to provide comfort After 30 minutes span
ng tiyan ko inflammation as nursing interventions, comfort (e.g.. and alleviate the pain felt of nursing
pagkatapos ko manifested by the patient will be able change of position interventions, the
kumain at dumumi” the pain scale of to: & use of heating patient was able to:
as verbalized by the 7 out of 10 pad applied into
patient. ● Report decreased the abdomen) ● Breathing exercises relates ● Report pain is
pain as evidenced by the body, alleviating pain relieved as
Objective cues: having a pain scale ● Teach patient a and promoting relief evidenced by
● Increased RR, of 4 out of 10 specific relaxation having a pain scale
PR, and BP ● Have a decreased strategy (eg, slow, of 5 out of 10.
value in VS rhythmic breathing ● To prevent fatigue ● Have a decreased
RR: 22cpm RR: 18cpm or deep breath) value in VS
PR: 110bpm PR: 95bpm RR: 20cpm
BP: 140/90 BP: 120/90mmHg ● Encourage ● To monitor effectiveness PR: 100bpm
mmHg ● Follow prescribed adequate rest of medical treatment for BP: 130/90mmHg
pharmacologic periods the relief of heartburn and ● Follow prescribed
● Restlessness regimen stomach pain. The time of pharmacologic
● Pacing ● Demonstrate use of ● Assess the monitoring of vital signs regimen
● Guarding relaxation skills & patient’s vital may depend on the peak ● Demonstrate use of
behavior on the diversional signs and time of the drug relaxation skills &
abdominal area activities characteristics of administered. diversional
● Diaphoresis pain at least 30 activities.
● A pain scale of Long Term Goal: minutes after To rest the bowel to prevent
7 out of 10 After 3 days of nursing administration of further feeling of pain GOAL PARTIALLY
interventions the medication MET
patient will report pain
is relieved or controlled Long Term Goal:
and appear to be ● Anti-inflammatory drugs, After 3 days of nursing
relaxed and able to such as interventions the patient
sleep and rest methylprednisolone IV, able to report the pain is
appropriately reduce the inflammation of controlled and appear to
● Instruct the patient the bowel, relieving pain be relaxed and able to
to follow liquid sleep and rest
diet follow with appropriately
solid diet as ● To decrease intestinal
tolerated motility GOAL PARTIALLY
MET
Dependent:
● Administer anti-
inflammatory
drugs with doctor's
order.
● Administer anti-
cholinergic or
antispasmodic
medications such
as propantheline
bromide 30
minutes before
meal as prescribed
Collaborative:
● Implement
prescribed dietary
modifications by
the dietician
AGANGLIONIC MEGACOLON (HIRSCHSPRUNG DISEASE)
Definition
● Hirschsprung disease is a birth defect in which some nerve cells are missing in the
large intestine, so a child's intestine can't move stool and becomes blocked.
● Characterized by persistent constipation resulting from partial or complete intestinal
obstruction of mechanical origin.
Clinical Manifestations
● Abdominal distention
● Chronic constipation/ribbonlike stools
● Palpable intestinal loops
● Absence/delayed passage of meconium.
● Vomiting
● Malnourishment
RESULT INTERPRETATION
RECTAL BIOPSY
Pathophysiology
Nursing Care Plan
• Administration of enemas
Therapeutic • Corticosteroids, sulfonamides using isotonic solution
Management (sulfasalazine [Azulfidine]) (normal saline or 0.9% NaCl)
• Antibiotics • Colostomy
• Parenteral nutrition • Dissection and removal of
• Partial or complete colectomy, affected section with
with ileostomy or anastomosis anastomosis of the intestine
https://www.scribd.com/document/106331664/CROHN-S-DISEASE
https://nurseslabs.com/7-inflammatory-bowel-disease-nursing-care-plans/
https://www.aafp.org/afp/2011/1215/p1365.html
https://www.researchgate.net/figure/Findings-on-barium-study-of-the-colon-in-tuberculosis-
and-Crohns-disease-A-Barium_fig2_49792030
https://nurseslabs.com/hirschsprung-disease-aganglionic-megacolon/
Smeltzer, S. C., Bare, B. G., Hinkle, J. L., & Cheever, K. H. (2009). Brunner and Suddarth’s
Textbook of Medical Surgical Nursing, 12th Edition (12th ed.). Lippincott Williams &
Wilkins.